Kali, Inc. announced plans with Puration, Inc. and Nouveau Life Pharmaceuticals, Inc. to form a joint venture (JV) company to develop cannabis pharmaceutical products. Puration has previously licensed the NCM Biotech patent for use in specific commercial applications. Puration brings its commercial experience to the planned pharmaceutical JV.

In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar.